Brief: Longboard Pharmaceuticals Inc, On November 15, Increased Size Of Board From Six Directors To Seven Directors
17/11/2021 14:08
Nov 17 (Reuters) - Longboard Pharmaceuticals Inc LBPH.O :
* LONGBOARD PHARMACEUTICALS INC - ON NOVEMBER 15, INCREASED
SIZE
OF BOARD FROM SIX DIRECTORS TO SEVEN DIRECTORS
Source text for Eikon: ID:
Further company coverage: LBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions